
Ivamax 7.5 Tablet
Marketer
Johnlee Pharmaceuticals Pvt Ltd
Salt Composition
Ivabradine (7.5mg)
Overview Ivamax 7.5 Tablet
Cardilux 7.5mg tablets treat angina pectoris (chest pain linked to heart problems) and long-term heart failure. It improves cardiac function by reducing heart rate, thus easing chest pain and lowering hospitalization risk in heart failure patients. Dosage varies depending on the condition treated. As treatment is typically ongoing, cessation requires physician consultation. Always take with food at the same time daily. Overdose may cause excessive bradycardia, breathlessness, and fatigue; seek immediate medical assistance if this occurs. Common side effects include transient visual disturbances, bradycardia, hypertension, atrial fibrillation, dizziness, blurred vision, and electrocardiographic changes. Serious adverse events such as syncope and significant cardiac rhythm disturbances warrant immediate medical attention. Refrain from driving until the drug's effects are known. Do not use Cardilux 7.5mg if you have severe hepatic impairment, resting bradycardia, or arrhythmia. It's contraindicated in patients with severe hypotension and recently exacerbated heart failure. This medication interacts with certain antihypertensives, antifungals, and antiretrovirals. Avoid use during pregnancy, attempts to conceive, or breastfeeding.
Primary Ingredients of Ivamax 7.5 Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Ivamax 7.5 Tablet
Managing angina pectoris and heart failure.
Major Benefits of Ivamax 7.5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ivamax 7.5 Tablet whole; do not crush, chew, or fracture it. Administer this medication with a meal.
Common Side effects of Ivamax 7.5 Tablet:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Ivamax 7.5 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ivamax 7.5mg tablets should be administered with a meal.
How Ivamax 7.5 Tablet works:
Cardio-rate modulator Ivamax 7.5mg tablets decrease cardiac frequency, thereby diminishing the heart's oxygen demand and improving overall cardiac function.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ivamax 7.5 Tablet lacks established safety data. Physician consultation is advised.
PregnancyUNSAFE
Using Ivamax 7.5 Tablet during pregnancy poses a serious risk. Pregnant women should consult their physician; research in animals and pregnant humans indicates substantial adverse effects on fetal development.
Breast feedingUNSAFE
Lactation and the use of Ivamax 7.5 mg tablets are incompatible due to a potential risk of infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by Ivamax 7.5 Tablet side effects. These may include transient visual disturbances, primarily phosphenes. Night driving should be approached with caution due to the potential for such light flashes.
KidneyCAUTION
Patients with severe kidney impairment should use Ivamax 7.5mg tablets cautiously, as dose modification may be necessary. Physician consultation is recommended. Data regarding Ivamax 7.5mg tablet use in this patient population is limited.
LiverCAUTION
Patients with hepatic impairment should use Ivamax 7.5 mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Ivamax 7.5 mg tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Ivamax 7.5 Tablet :
Omit any missed dose of Ivamax 7.5 Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ivamax 7.5 Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzazepine-based compound |
| Developing Habits | No. |
| Treatment Category | HEART |
| Action Class | Sodium channel blockers targeting the sinoatrial node |
